Generation of robust cytotoxic T lymphocytes against prostate specific antigen by transduction of dendritic cells using protein and recombinant adeno-associated virus

被引：0
作者：
Mahendran Mahadevan
Yong Liu
Changxuan You
Rongcheng Luo
Hong You
Jawahar L. Mehta
Paul L. Hermonat
机构：
[1] University of Arkansas for Medical Sciences,Gene Therapy Program
[2] University of Arkansas for Medical Sciences,Department of Obstetrics and Gynecology, Slot 518
[3] University of Arkansas for Medical Sciences,Department of Internal Medicine
[4] Southern medical University,Department of Oncology, Nanfang Hospital
来源：
Cancer Immunology, Immunotherapy | 2007年 / 56卷
关键词：
Dendritic cells; Adeno-associated virus; Prostate cancer; PSA; Integration; Transduction; Immunotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Prostate cancer is the most common male cancer and there is an urgent need for adjuvant therapy such as immunotherapy. Recombinant adeno-associated virus type 2 (rAAV) vectors are useful for antigen gene-loading of human dendritic cells (DC) and for the rapid generation of cytotoxic T lymphocytes (CTL). In this study, we report a protocol for AAV-loading of DC with the AAV-loading of self-antigen prostate specific antigen (PSA) resulting in generation of CTL. PSA and cytokine expression, Cell surface marker analysis of DC and CTL cells were done using a FACScalibur flow cytometer. Chromium-51 release assay was used to analyze the killing activity of CTL. It was found that AAV-loading of DC with the PSA gene is superior to PSA protein loading of the same antigen for generating effective CTL. AAV/PSA-loading of DC was found to result in: (1) strong, rapid PSA-specific, MHC Class I-restricted CTL, (2) PSA expression in DC, (3) high CD80, CD83, and CD86 expression on DC, (4) high level of IL-12 and low level of IL-10 in DC, (5) T cell populations with significant interferon γ (IFNγ) expression, but low IL-4 expression, (6) high proliferation of T cell populations, (7) high CD8:CD4 and CD8:CD56 T cell ratios. The reason for generation of robust CTL is partly explained by the characteristics of DC and CTL described. This protocol may be useful for adoptive immunotherapy against self antigens such as PSA for prostate cancer.
引用
收藏
页码：1615 / 1624
页数：9
相关论文
共 206 条
[1]  
Almirah F(2006)DU-145 and PC-3 human prostate cancer cell lines express androgen receptor: implications for the androgen receptor functions and regulation FEBS Lett 580 2294-2300
[2]  
Chen J(2001)Isolation of highly infectious and pure adeno-associated virus type 2 vectors with a single-step gravity-flow column Hum Gene Ther 12 71-76
[3]  
Basrawala Z(1997)Efficient retrovirus-mediated gene transfer of dendritic cells generated from CD34+ cord blood cells under serum-free conditions. Human Gene Ther 8 1651-1658
[4]  
Xin H(1997)Dendritic cells as immunogens for human CTL responses Adv Exp Med Biol 417 383-387
[5]  
Choubey D(2007)Characterization of human prostate and breast cancer cell lines for experimental T cell-based immunotherapy Prostate 67 389-395
[6]  
Auricchio A(2002)Efficient generation of cytotoxic T lymphocytes against cervical cancer cells by adeno-associated virus-human papilloma virus type 16 E7 antigen transduction into dendritic cells Eur J Immunol 32 30-38
[7]  
Hildinger M(1999)A helper virus-free packaging system for recombinant adeno-associated virus vectors Gene 238 397-405
[8]  
O’Connor E(1997)In vitro generation of human cytotoxic T lymphocytes specific for peptides derived from prostate-specific antigen J Natl Cancer Inst 89 293-300
[9]  
Gao GP(2004)Dendritic cell based vaccines: progress in immunotherapy studies for prostate cancer J Urol 172 2532-2538
[10]  
Wilson JM(2001)Gene therapy for prostate cancer: current status and future prospects J Urol 166 1220-1233
12345678910